Inventor · disambiguated record
Walter Vifian
Also filed as: VIFIAN WALTER
17 granted patents·8 pending applications·27 citations·filing 2007–2023
89Inventor score
Top patents by PatentIndex Score
25 records- 0184US9751870B2Oxytocin receptor agonists for the treatment of CNS diseasesHOFFMANN LA ROCHE·Filed 2015·Granted Sep 5, 2017·5 cites·7 claims
- 0280US10246468B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2016·Granted Apr 2, 2019·3 cites·19 claims
- 0380US7470684B2Spiropiperidine derivatives as NK3 antagonistsHOFFMANN LA ROCHE·Filed 2007·Granted Dec 30, 2008·6 cites·31 claims
- 0478US9540397B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2015·Granted Jan 10, 2017·2 cites·24 claims
- 0578US8618303B2Pyrrolidine derivativesKNUST HENNER·Filed 2012·Granted Dec 31, 2013·4 cites·17 claims
- 0676US11440915B2Triazolo-azepine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Sep 13, 2022·1 cites·13 claims
- 0774US9023852B21, 2, 4-thiadiazol-5-ylpiperazine derivatives useful in the treatment of neurodegenerative diseasesGRIFFIOEN GERARD·Filed 2012·Granted May 5, 2015·3 cites·22 claims
- 0869US9187440B2Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's diseaseGRIFFIOEN GERARD·Filed 2012·Granted Nov 17, 2015·1 cites·15 claims
- 0967US8324250B2Piperidine derivatives as NK3 receptor antagonistsKNUST HENNER·Filed 2010·Granted Dec 4, 2012·1 cites·7 claims
- 1065US8507535B2Methyl-pyrrolidine ether derivativesNETTEKOVEN MATTHIAS·Filed 2011·Granted Aug 13, 2013·1 cites·10 claims
- 1165US2024010659A1New thiadiazolopyrimidone derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1265US2024002407A1Thienopyrimidinone derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1364US2024018163A1New thiazolopyrimidinone derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1462US2025179092A1Pyrido[1,2-a]pyrimidin-4-one derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1560US9226916B2Pyrrolidine derivativesKNUST HENNER·Filed 2013·Granted Jan 5, 2016·0 cites·34 claims
- 1658US2009076081A1Piperidine derivatives as nk3 antagonistsKNUST HENNER·Filed 2008·Application pending·0 cites
- 1754US8318749B2Quinazoline derivatives as NK3 receptor antagonistsKNUST HENNER·Filed 2009·Granted Nov 27, 2012·0 cites·19 claims
- 1853US10696691B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Jun 30, 2020·0 cites·6 claims
- 1952US9346786B2Pyrrolidine compoundsHOFFMANN LA ROCHE·Filed 2013·Granted May 24, 2016·0 cites·15 claims
- 2051US2011152233A1Pyrrolidine compoundsKNUST HENNER·Filed 2010·Application pending·0 cites
- 2151US2011144081A1Pyrrolidine derivativesKNUST HENNER·Filed 2010·Application pending·0 cites
- 2250US11414420B2Pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Aug 16, 2022·0 cites·14 claims
- 2344US2011021565A1Piperidine derivatives as nk3 antagonistsKNUST HENNER·Filed 2010·Application pending·0 cites
- 2443US9808456B2Piperazine thiazole derivatives useful in the treatment of tauopathies such as Alzheimer's diseaseREMYND NV·Filed 2015·Granted Nov 7, 2017·0 cites·30 claims
- 2537US8324248B2Piperidine derivatives as NK3 receptor antagonistsKNUST HENNER·Filed 2010·Granted Dec 4, 2012·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →